Iconovo AB (OSTO:ICO) 6-Month Price Index: 1.07 (As of Sep. 14, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:ICO Iconovo AB OSTO:ICO
31 GF Score
Price kr1.22
GF Value kr0.34
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Iconovo AB 6-Month Price Index?

Iconovo AB OSTO:ICO -10.99% 31 6-Month Price Index is 1.07 as of Sep. 14, 2026. GuruFocus rates OSTO:ICO with a GF Score™ of 31/100 and a GF Value™ of kr0.34 (Significantly Overvalued). The stock has 4 warning signs investors should review.

6-Month Price Index is an intermediate-term momentum that shows the price change relative to 6-month ago. It’s calculated by current share price divided by share price 6-months ago. As of today (2026-09-14), Iconovo AB's 6-Month Price Index is 1.07.


Iconovo AB  (OSTO:ICO) 6-Month Price Index Explanation

Price Index (PI) also called momentum. Strategies involving Price Index are also known as momentum strategies as they allow investors to profit from a company’s stock price. 6-Month Price Index is an intermediate-term momentum that shows the price change relative to 6-month ago.

The investment strategy for momentum investors is to buy winners and sell losers. That is, buy stocks that performed well and sell stocks that performed poorly in the past.


Iconovo AB 6-Month Price Index Related Terms


OSTO:ICO vs ABT, SYK, MDT: 6-Month Price Index Comparison

For the Medical Devices subindustry, Iconovo AB's 6-Month Price Index, along with its competitors' market caps and 6-Month Price Index data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

OSTO:ICO
31GF Score
Iconovo AB OSTO:ICO
6-Month Price Index is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Iconovo AB  (OSTO:ICO) 6-Month Price Index Calculation

6-Month Price Index is calculated as following:

6-Month Price Index=Current Share Price / Share Price 6-Months Ago

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about 6-Month Price Index →
What does a 6-Month Price Index of 1.07 mean?
Iconovo AB (OSTO:ICO) has a 6-Month Price Index of 1.07 as of Sep. 14, 2026. 6-Month Price Index is an intermediate-term momentum that shows the price change relative to 6-month ago. View historical data on Iconovo AB and its competitors.
Is Iconovo AB's 6-Month Price Index too high?
Iconovo AB's current 6-Month Price Index is 1.07. Overall, Iconovo AB has a GF Score™ of 31/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Iconovo AB's 6-Month Price Index compare to ABT and SYK?
Iconovo AB's 6-Month Price Index of 1.07 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 6-Month Price Index for a Medical Devices & Instruments company?
A good 6-Month Price Index depends on the Medical Devices & Instruments industry context. However, 6-Month Price Index should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 6-Month Price Index mean?
A high 6-Month Price Index can signal that a stock is expensive relative to its fundamentals. 6-Month Price Index is an intermediate-term momentum that shows the price change relative to 6-month ago. View historical data on Iconovo AB and its competitors. Iconovo AB's current 6-Month Price Index is 1.07. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Iconovo AB stock overvalued right now?
Based on GuruFocus' analysis, Iconovo AB (OSTO:ICO) is currently considered Significantly Overvalued. The stock's GF Value™ is kr0.34, compared to a current price of kr1.22 — trading 257.4% above its estimated fair value. The current 6-Month Price Index is 1.07. Iconovo AB's overall GF Score™ is 31/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 6-Month Price Index calculated?
6-Month Price Index is calculated from a company's financial statements. For Iconovo AB (OSTO:ICO), the current 6-Month Price Index is 1.07 as of Sep. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Iconovo AB (OSTO:ICO) Overvalued in 2026?

Based on GuruFocus' analysis, Iconovo AB stock appears to be overvalued. The current stock price of kr1.22 is trading 257.4% above its estimated GF Value™ of kr0.34. GuruFocus considers Iconovo AB to be Significantly Overvalued.

Key valuation signals for OSTO:ICO:

  • 6-Month Price Index: 1.07
  • GF Value™: kr0.34 vs. price of kr1.22 (257.4% above fair value)
  • GF Score™: 31/100 with 4 warning signs

No single metric tells the full story. See the OSTO:ICO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Iconovo AB Business Description

Address Ideongatan 3 A-B, Delta 6, Lund, SWE, SE-223 62
Iconovo AB develops new inhaled medicinal products in collaboration with international pharmaceutical companies. The company provides several types of patent-protected inhalers that can generate commercial opportunities in the development of novel pharmaceuticals and vaccines and at patent expirations for established pharmaceuticals. The project is a generic version of the asthma and COPD product Symbicort.
31GF Score

Get the complete analysis for OSTO:ICO

6-Month Price Index is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr1.22
Price
kr0.34
GF Value